Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Cadranel

Showing results (11-20 of 329) with videos related to

Pageof 33
Sort By:
Frontiers in Medicine|December 13, 2021
Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted TherapiesThierry Berghmans, Jacques Cadranel, Bogdan Grigoriu
Bulletin Du Cancer|January 7, 2017
Elizabeth Fabre, Nicola Pécuchet, Jacques Cadranel
Lung Cancer (Amsterdam, Netherlands)|February 26, 2008
Osteoblastic metastases in non-small cell lung cancer and its possible significanceDavid Garfield, Jacques Cadranel, Nicola Normanno
Pediatric Pulmonology|March 17, 2010
Rituximab-induced pneumonitis: steroid therapy or not?Huguette Lioté, Jacques Cadranel, Frédéric Lioté
La Revue Du Praticien|July 26, 2003
[Bronchoalveolar carcinoma]Marie Wislez, Jacques Cadranel, Bernard Milleron
Lung Cancer (Amsterdam, Netherlands)|September 11, 2012
Prognostic factor for non-small cell lung cancer with bone metastases at the time of diagnosisDavid Garfield, Nicola Normanno, Jacques Cadranel
La Revue Du Praticien|December 6, 2011
[When pneumonia does not respond to antibiotic therapy]Charles Mayaud, Muriel Fartoukh, Jacques Cadranel
Respiratory Medicine and Research|May 3, 2022
Invited editorial: Q and A on hereditary lung cancerPatrick R Benusiglio, Vincent Fallet, Jacques Cadranel
American Journal of Respiratory and Critical Care Medicine|February 16, 2017
Acute Exacerbation of Idiopathic Pulmonary FibrosisJean-Marc Naccache, Jacques Cadranel, Hilario Nunes
Medical Oncology (Northwood, London, England)|December 7, 2018
HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH GroupAurelien Gobert, Jean-Philippe Spano, Jacques Cadranel
Pageof 33

Showing results (11-20 of 329) with videos related to

Sort By:
Pageof 33
Frontiers in Medicine|December 13, 2021
Editorial: New Advances in Non-small Cell Lung Cancer Management: Immune Modulation and Targeted TherapiesThierry Berghmans, Jacques Cadranel, Bogdan Grigoriu
Bulletin Du Cancer|January 7, 2017
Elizabeth Fabre, Nicola Pécuchet, Jacques Cadranel
Lung Cancer (Amsterdam, Netherlands)|February 26, 2008
Osteoblastic metastases in non-small cell lung cancer and its possible significanceDavid Garfield, Jacques Cadranel, Nicola Normanno
Pediatric Pulmonology|March 17, 2010
Rituximab-induced pneumonitis: steroid therapy or not?Huguette Lioté, Jacques Cadranel, Frédéric Lioté
La Revue Du Praticien|July 26, 2003
[Bronchoalveolar carcinoma]Marie Wislez, Jacques Cadranel, Bernard Milleron
Lung Cancer (Amsterdam, Netherlands)|September 11, 2012
Prognostic factor for non-small cell lung cancer with bone metastases at the time of diagnosisDavid Garfield, Nicola Normanno, Jacques Cadranel
La Revue Du Praticien|December 6, 2011
[When pneumonia does not respond to antibiotic therapy]Charles Mayaud, Muriel Fartoukh, Jacques Cadranel
Respiratory Medicine and Research|May 3, 2022
Invited editorial: Q and A on hereditary lung cancerPatrick R Benusiglio, Vincent Fallet, Jacques Cadranel
American Journal of Respiratory and Critical Care Medicine|February 16, 2017
Acute Exacerbation of Idiopathic Pulmonary FibrosisJean-Marc Naccache, Jacques Cadranel, Hilario Nunes
Medical Oncology (Northwood, London, England)|December 7, 2018
HIV-associated cancers: the role of a unique multidisciplinary board to optimize patient's care behalf the CANCERVIH GroupAurelien Gobert, Jean-Philippe Spano, Jacques Cadranel
Pageof 33